Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Winblad

Showing results (11-20 of 572) with videos related to

Pageof 58
Sort By:
Acta Neurobiologiae Experimentalis|April 1, 2004
Therapeutic strategies for Alzheimer's disease based on new molecular mechanismsDorota Religa, Bengt Winblad
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?Fabrizio Piazza, Bengt Winblad
Lakartidningen|March 16, 2006
[Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life]Johan Lökk, Bengt Winblad
International Journal of Geriatric Psychiatry|September 16, 2003
Treating the full spectrum of dementia with memantineBengt Winblad, Vesna Jelic
International Journal of Geriatric Psychiatry|January 22, 2005
Biomarkers for apoptosis in Alzheimer's diseaseMaria Ankarcrona, Bengt Winblad
International Psychogeriatrics|September 30, 2005
Societal burden and economics of vascular dementia: preliminary results from a Swedish-population-based studyAnders Wimo, Bengt Winblad
Nature Clinical Practice. Neurology|February 7, 2007
Mild cognitive impairment: continuing controversiesKatie Palmer, Bengt Winblad
Nature Reviews. Neurology|December 31, 2015
Alzheimer disease. Donepezil and nursing home placement--benefits and costsVesna Jelic, Bengt Winblad
Neuron|May 27, 2003
Hints of a therapeutic vaccine for Alzheimer's?Bengt Winblad, Kenneth I Blum
Experimental Gerontology|October 3, 2009
Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspectsAngel Cedazo-Minguez, Bengt Winblad
Pageof 58

Showing results (11-20 of 572) with videos related to

Sort By:
Pageof 58
Acta Neurobiologiae Experimentalis|April 1, 2004
Therapeutic strategies for Alzheimer's disease based on new molecular mechanismsDorota Religa, Bengt Winblad
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?Fabrizio Piazza, Bengt Winblad
Lakartidningen|March 16, 2006
[Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life]Johan Lökk, Bengt Winblad
International Journal of Geriatric Psychiatry|September 16, 2003
Treating the full spectrum of dementia with memantineBengt Winblad, Vesna Jelic
International Journal of Geriatric Psychiatry|January 22, 2005
Biomarkers for apoptosis in Alzheimer's diseaseMaria Ankarcrona, Bengt Winblad
International Psychogeriatrics|September 30, 2005
Societal burden and economics of vascular dementia: preliminary results from a Swedish-population-based studyAnders Wimo, Bengt Winblad
Nature Clinical Practice. Neurology|February 7, 2007
Mild cognitive impairment: continuing controversiesKatie Palmer, Bengt Winblad
Nature Reviews. Neurology|December 31, 2015
Alzheimer disease. Donepezil and nursing home placement--benefits and costsVesna Jelic, Bengt Winblad
Neuron|May 27, 2003
Hints of a therapeutic vaccine for Alzheimer's?Bengt Winblad, Kenneth I Blum
Experimental Gerontology|October 3, 2009
Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspectsAngel Cedazo-Minguez, Bengt Winblad
Pageof 58